Fig. 2From: Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trialEndoscopic images of patient strata of polyposis: a pre-colectomy, b rectal/pouch, and c duodenal (Spigelman stage 3/4)Back to article page